Hester Biosciences Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Hester Biosciences hat ein Gesamteigenkapital von ₹3.0B und eine Gesamtverschuldung von ₹2.4B, wodurch sich der Verschuldungsgrad auf 78.9% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ₹6.6B bzw. ₹3.6B. Hester Biosciences Das EBIT des Unternehmens beträgt ₹471.2M, so dass der Zinsdeckungsgrad 2.4 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ₹153.0M.

Wichtige Informationen

78.9%

Verhältnis von Schulden zu Eigenkapital

₹2.39b

Verschuldung

Zinsdeckungsgrad2.4x
Bargeld₹153.04m
Eigenkapital₹3.03b
Gesamtverbindlichkeiten₹3.59b
Gesamtvermögen₹6.62b

Jüngste Berichte zur Finanzlage

Recent updates

Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price

Jun 12
Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price

Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00

Aug 01
Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00

Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?

Mar 03
Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?

Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?

Feb 13
Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?

What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?

Jan 26
What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?

Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Jan 11
Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 25
Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10
Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

Nov 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?

Nov 10
How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?

If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns

Oct 26
If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns

What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Oct 05
What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?

Sep 14
Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

Aug 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?

Aug 07
How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?

Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?

Jul 07
Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: HESTERBIODie kurzfristigen Aktiva des Unternehmens (₹2.1B) übersteigen seine kurzfristigen Passiva (₹1.1B).

Langfristige Verbindlichkeiten: HESTERBIODie kurzfristigen Vermögenswerte des Unternehmens (₹2.1B) decken seine langfristigen Verbindlichkeiten (₹2.5B) nicht.


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: HESTERBIODie Nettoverschuldung im Verhältnis zum Eigenkapital (73.9%) wird als hoch angesehen.

Schulden abbauen: HESTERBIODas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 49.4% auf 78.9% gestiegen.

Schuldendeckung: HESTERBIODie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (20.1%).

Zinsdeckung: HESTERBIODie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (2.4x Deckung) nicht gut gedeckt.


Bilanz


Entdecken Sie finanziell stabile Unternehmen